Neurogranin (48-76), human

O=C(NCC(N[C@@H](CCC(O)=O)C(N[C@@H](CCCNC(N)=N)C(NCC(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(NCC(N1[C@@H](CCC1)C(NCC(N2[C@@H](CCC2)C(NCC(NCC(N3[C@@H](CCC3)C(NCC(NCC(N[C@@H](C)C(NCC(N[C@@H](C(C)C)C(N[C@@H](C)C(N[C@@H](CCCNC(N)=N)C(NCC(NCC(N[C@@H](C)C(NCC(NCC(NCC(N4[C@@H](CCC4)C(N[C@@H](CO)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CO)N

[1]Hlin Kvartsberg, et al. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease. Alzheimers Dement. 2015 Oct;11 (10) :1180-90.|[2]Hlin Kvartsberg, et al. Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls. Alzheimers Res Ther. 2015; 7 (1) : 40.